C-CAST: Virtual Clinical Trials in Japan – Under COVID-19 pandemic –
C-CAST is a mini-video series presented by CMIC Group. As the pioneer and leading CRO in Japan, we provide you with short and useful videos about pharmaceutical and healthcare industry, including educational contents, leader & expert interviews, and more. Watch the video and learn about the market/industry trend, latest regulatory information, and new technologies for your product development in the U.S., Japan, and broader Asia.
In March 2020, at the height of the COVID-19 outbreak, the FDA issued a new guidance providing advice to pharmaceutical companies about how to run virtual clinical trials, not just for potential virus remedies but for any drug they are developing.
The Japan regulatory authority also announced regulatory updates considering COVID-19 outbreak. Listen to our expert talk about the latest virtual clinical trial situation in Japan
Topics include:
- Impact of COVID-19
- Latest regulatory trend
- Virtual clinical trials in Japan
Speaker:
Shuta Mitomo
Division Head/Operating Officer, Digital and Innovation Planning,
CRO business, CMIC Group
